These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2230626

  • 1. Ciprofloxacin in severe infections.
    Aswapokee N, Pruksachatvuthi S, Aswapokee P.
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA, Quintero-Pérez NP, Morales-Reyes JJ, Huitrón-Ramírez JA, Rodríguez-Chagollán JJ, Rodríguez-Noriega E.
    Am J Med; 1987 Apr 27; 82(4A):242-6. PubMed ID: 3555042
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Karimi K.
    Indiana Med; 1990 Apr 27; 83(4):266-9. PubMed ID: 2185309
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F, Torroba L, Buzón L, Martínez-Beltrán J, Loza E, Baquero F.
    Enferm Infecc Microbiol Clin; 1989 May 27; 7(5):261-5. PubMed ID: 2490722
    [Abstract] [Full Text] [Related]

  • 14. [Ciprofloxacin treatment in bacterial skin infections].
    Mohr CP, Küchmeister B, Reinel D, Ulrich R.
    Fortschr Med; 1989 May 30; 107(16):367-9. PubMed ID: 2737587
    [Abstract] [Full Text] [Related]

  • 15. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez C.
    Arch Intern Med; 1989 Nov 30; 149(11):2579-83. PubMed ID: 2684078
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P, Manara G, Bianchi L, Piccioni PD, Grassi C.
    G Ital Chemioter; 1989 Nov 30; 36(1-3):89-94. PubMed ID: 2488917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 30; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 20. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL, Berenson CS, Greco TP, Mangi RJ, Sims M, Thornton GF, Andriole VT.
    Am J Med; 1987 Apr 27; 82(4A):303-6. PubMed ID: 3555052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.